SenzaGen has received questions from customers and partners about how COVID-19 has affected our daily operations. We continue to monitor the development of the COVID-19 epidemic closely and recognize that this situation represents an unprecedented challenge to the daily lives of our communities across the globe. To date, we continue to offer our full range […]
Join SenzaGen’s web-based conference on “Difficult-to-test” substances and regulatory testing in place of our exhibitor hosted session at SOT 2020 Take this chance and participate in our web-based conference on the latest news about GARD™ and how customers use the assays for skin and respiratory sensitization testing. Key takeaways Insights on sensitization assessment of “difficult-to-test” […]
SenzaGen has received questions from customers and partners about how COVID-19 has affected our daily operations. We continue to monitor the development of the COVID-19 epidemic closely and recognize that this situation represents an unprecedented challenge to the daily lives of our communities across the globe. SenzaGen acts in adherence with the authorities’ guidelines in […]
Andy Forreryd1, Joshua Schmidt1, Robin Gradin1, Florence Burleson, Helge Gehrke3, Henrik Johansson1. 1SenzaGen AB, Lund, Sweden. 2Burleson Research Technologies, Morrisville, NC, USA. 3Eurofins BioPharma Product Testing Munich GmbH, Planegg, Germany. Sensitization of the respiratory tract by sensitizing chemicals may lead to severe bronchoconstriction and asthma-like symptoms with a potentially fatal outcome. However, proactive identification and […]
Join SenzaGen’s free web-based SOT 2020 poster presentation session Don’t miss the opportunity to participate in our web-based conference on the latest news about the GARD™ assays for skin and respiratory sensitization testing. Key takeaways – Comparative study: GARDskin for challenging substances – How to test UVCBs and Mixtures – Formal validation of GARDpotency for […]
Did you miss our popular webinar ‘GARD technology: Genomics and Machine Learning’ last year? Here is a new opportunity to participate in a live webinar presented by GARD experts at SenzaGen followed by a Q&A session. Join us and you’ll learn the principles of the technology platform and get an updated overview of its broad […]
Journal of Proteomics Available online 30 January 2020, 03647. https://doi.org/10.1016/j.jprot.2020.103647 Tim Lindberg, Renato Ivan de Ávila, Kathrin S. Zeller, Fredrik Levander, Dennis Eriksson, Aakash Chawaded, Malin Lindstedt Highlights Pure glyphosate was classified as a non-sensitizer using in vitro assessment. POEA, POEA+glyphosate mixture and formulations were identified as skin sensitizers. MS analysis identified protein groups related […]
Here is an easy guide to how GARD skin and respiratory sensitization in vitro assays can help you through various challenges in your product life cycle. Many of our customers use our assays as an integrated part during their product development phase, for example testing for candidate ingredients, formulations or finished products, including various difficult-to-test […]
We wish you a truly happy holiday season, and we look forward to seeing you again in the new year.
Our CEO presented at Vator Unicorn Summit in Stockholm last week and in the video below you can watch him explaining about SenzaGen’s change from a research organization to one with a strong focus on commercialization. Vator Unicorn Summit, November 27, 2019
